Tags |
|
|
Links |
|
|
Advice Pool - Better Medical Reports for Life Insurance
In about every four in ten cases when someone applies for Life Insurance, the insurer has to obtain a medical report from a General Practitioner.
They nee
They nee
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
d the reports when someone has declared that they have a medical condition on their life insurance application form. The applicant then has to give consent
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
that the insurance company can gain a medical report from their GP. The GP gets called on to supply information about the specifics of that medical conditi
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
on and any other relevant information.
But despite the fact that these are often costly to get hold of for insurance companies, there have been cases wher
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
GPs have not been supplying the quality information that they need. In some cases, they simply print out the computerised records of their patients and se
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
nd them to the insurers.
This is not just a problem because insurers have paid the doctors to supply specific reports, but that this approach means that t
This is not just a problem because insurers have paid the doctors to supply specific reports, but that this approach means that t
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
ey often do not get the specific information they need. And on top of this, the GP winds up breaching their patient’s confidentiality because the insurance
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
company gets extra information about the applicant’s medical state that they do not need to know. It is a situation both the British Medical Association (
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
MI) and the Association of British Insurers (ABI) would not want to occur and goes against the agreement between both parties that medical information coul
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
d be obtained for the purpose of Life Insurance applications.
But because of concerns, a new agreement between both the BMI and ABI has been made where GP
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
have to provide high quality reports to the insurance companies for fees that will consistently rise by 6% over five years.
The fees were re-set as part
The fees were re-set as part
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
f the negotiation process for reports, supplementary reports and medical examinations.
An ABI spokesman for health insurance says that the reports help pe
An ABI spokesman for health insurance says that the reports help pe
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
ople to gain much needed health insurance, such as life insurance policies that they would otherwise not normally be able to obtain.
“This agreement is go
“This agreement is go
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
d news for customers because again the BMA has pledged to uphold high standards from doctors. This includes making sure that doctors fill in forms personal
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
ly and accurately, rather than simply sending printouts of medical records, which does not give the insurer the information that it needs,” he says. “The d
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
al provides both stability and certainty.”
For a GP report that needs to be obtained in the year from 2006 -2007, the cost is ?74.70. That increases to ?7
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
9.20 for the next year and ?84.00 after that. For a supplementary report the cost increases from ?19.10 this year, to ?20.20 the year after that and ?21.40
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
for the year after that again.
And medical examinations will this year cost ?82.20, increasing to ?87.10 in the year after that and then ?92.30 in the fol
And medical examinations will this year cost ?82.20, increasing to ?87.10 in the year after that and then ?92.30 in the fol
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
lowing year.
The BMA tells GPs as part of the guidance in the new agreement that they need to recognise that life assurance is a “social good” and of bene
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
it to patients at significant points in their lives.
And that, as with other fee paid work, the reports should be completed thoroughly to justify the fees
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.advicepool.org.ua/article/125815/advicepool-Better-Medical-Reports-for-Life-Insurance.html">Better Medical Reports for Life Insurance</a>
BB link (for phorums):
[url=http://www.advicepool.org.ua/article/125815/advicepool-Better-Medical-Reports-for-Life-Insurance.html]Better Medical Reports for Life Insurance[/url]
Related Articles:
Small Business Computer Security, the Basics
Marketing and Making Money Online
Bookmark it:
|